Home » Topics » Regulatory

Regulatory
RSS

FDA approves first patch for treatment of migraine

Jan. 18, 2013

FDA approves Protein Sciences' Flublok seasonal influenza vaccine

Jan. 17, 2013

Biocon receives marketing authorization in India for itolizumab

Jan. 10, 2013

FDA approves Kineret for the treatment of NOMID

Jan. 10, 2013

FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS

Jan. 2, 2013

FDA grants accelerated approval for Sirturo in tuberculosis

Jan. 2, 2013

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

FDA expands approval of Tamiflu

Dec. 24, 2012

FDA approves Biotest's IVIG for primary humoral immunodeficiency

Dec. 21, 2012

GSK's four-strain seasonal influenza vaccine Fluarix Quadrivalent approved for use in U.S.

Dec. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...